<DOC>
	<DOCNO>NCT01148667</DOCNO>
	<brief_summary>Hypothesis : Probiotics use novel adjunct therapeutic approach atopic dermatitis . In addition balance gut microecology promote host immune defence , specific probiotic might aid control microbial colonization skin , thereby reduce proneness secondary infection typically cause sustain symptom . Thirty-nine infant atopic dermatitis , randomize three-month-period double-blind design receive extensively hydrolyse casein formula ( NutramigenR , Mead-Johnson , USA ) supplement ( n=19 ) without ( n=20 ) Lactobacillus rhamnosus GG ( ATCC 53103 ) 5.0 x 107 cfu/g achieve daily intake 3.4 x 109 cfu . Sampling ( blood faecal sample , cotton swab skin ) clinical examination infant , include SCORAD assessment determine severity atopic dermatitis , study visit ( entry one month three month thereafter ) .</brief_summary>
	<brief_title>Lactobacillus Rhamnosus GG : Interaction With Human Microbiota Immunity</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Caseins</mesh_term>
	<criteria>clinical diagnosis atopic dermatitis age 4 18 mo skin infection severe infection time enrollment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>atopic dermatitis</keyword>
	<keyword>barrier function</keyword>
	<keyword>gut</keyword>
	<keyword>probiotic</keyword>
	<keyword>skin</keyword>
</DOC>